SRS Capital Advisors Inc. increased its position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 99.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 659 shares of the company’s stock after buying an additional 329 shares during the quarter. SRS Capital Advisors Inc.’s holdings in Bath & Body Works were worth $26,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also made changes to their positions in the company. FMR LLC raised its position in shares of Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after buying an additional 2,501,828 shares during the period. KBC Group NV raised its position in shares of Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after buying an additional 1,683,160 shares during the period. Erste Asset Management GmbH purchased a new position in shares of Bath & Body Works in the 3rd quarter worth $50,483,000. Forest Avenue Capital Management LP raised its position in shares of Bath & Body Works by 19.1% in the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company’s stock worth $46,851,000 after buying an additional 235,173 shares during the period. Finally, Verition Fund Management LLC raised its position in shares of Bath & Body Works by 111.8% in the 3rd quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company’s stock worth $42,957,000 after buying an additional 710,333 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts have commented on BBWI shares. Robert W. Baird raised their price objective on Bath & Body Works from $45.00 to $47.00 and gave the company an “outperform” rating in a research report on Friday, February 28th. Deutsche Bank Aktiengesellschaft raised their price objective on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. TD Cowen raised their price objective on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Cowen reissued a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Telsey Advisory Group reissued an “outperform” rating and issued a $43.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $45.06.
Bath & Body Works Stock Performance
NYSE:BBWI opened at $32.66 on Friday. The company has a market capitalization of $7.07 billion, a price-to-earnings ratio of 7.97, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99. The stock has a 50-day simple moving average of $37.37 and a 200 day simple moving average of $34.18.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.45%. Bath & Body Works’s dividend payout ratio (DPR) is 21.98%.
Bath & Body Works declared that its board has approved a share buyback program on Thursday, February 27th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Is Myers Industries Poised for a Breakout?
- Why Invest in High-Yield Dividend Stocks?
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.